SCHEMBL19959138

SCHEMBL19959138

O=C(OCCO[C@H]1CCCNC1)N1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
TSHR P16473 1/20 0.43
RECQL P46063 2/20 0.40
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ALDH1A1 P00352 2/20 0.34
USP2 O75604 1/20 0.33
TPSAB1 Q15661 2/20 0.32
TPSD1 Q9BZJ3 2/20 0.32
TPSG1 Q9NRR2 2/20 0.32
P2RY12 Q9H244 1/20 0.32
TP53 P04637 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRM3 P20309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9363422 0.81 TPSAB1 (0.41) SMN1; SMN2TSHRRECQLMEN1KMT2A
SCHEMBL12114914 0.79 SMN1; SMN2 (0.42) SMN1; SMN2LMNAPOLBTSHRRECQL
SCHEMBL1317530 0.75 POLB (0.44) SMN1; SMN2LMNAPOLBTSHRRECQL
SCHEMBL30772071 0.75 SLC6A1 (0.37) SMN1; SMN2LMNATSHRKMT2AALDH1A1
SCHEMBL29370228 0.74 TPSAB1 (0.41) SMN1; SMN2TSHRRECQLKMT2AL3MBTL1
SCHEMBL19959156 0.71 CHRNB2 (0.40) SMN1; SMN2LMNATSHRKMT2ACHRM2
SCHEMBL28124706 0.71 CHRM2 (0.35) SMN1; SMN2LMNAPOLBTSHRKMT2A
SCHEMBL28583310 0.69 SMN1; SMN2 (0.62) SMN1; SMN2LMNAPOLBTSHRRECQL
SCHEMBL2146330 0.69 KMT2A (0.42) KMT2ATPSAB1TPSD1TPSG1P2RY12
SCHEMBL12520131 0.68 TPSAB1 (0.45) SMN1; SMN2LMNATSHRKMT2ATPSAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919856-B2 Cyclohexene compounds and use thereof GUANGZHOU HENOVCOM BIOSCIENCE CO. LTD. (CN) 2021-02-16 US disclosed
US-20190241520-A1 CYCLOHEXENE COMPOUNDS AND USE THEREOF GUANGZHOU HENOVCOM BIOSCIENCE CO. LTD. (CN) 2019-08-08 US disclosed
WO-2018045950-A1 CYCLOHEXENE COMPOUNDS AND USE THEREOF 广州市恒诺康医药科技有限公司 2018-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190241520-A1 CYCLOHEXENE COMPOUNDS AND USE THEREOF CYP51A1, FURIN, CYP21A2 SMN1; SMN2 3334/4885LMNA 1000/4885POLB 3811/4885
US-10919856-B2 Cyclohexene compounds and use thereof CYP51A1, FURIN, CYP21A2 SMN1; SMN2 3334/4885LMNA 1000/4885POLB 3811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.